FY2025 EPS Estimates for CME Group Lowered by Zacks Research

CME Group Inc. (NASDAQ:CME) – Stock analysts at Zacks Research reduced their FY2025 earnings per share (EPS) estimates for CME Group in a research report issued on Wednesday, November 12th. Zacks Research analyst Team now forecasts that the financial services provider will earn $11.04 per share for the year, down from their previous forecast of $11.13. The consensus estimate for CME Group’s current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group’s Q3 2027 earnings at $3.44 EPS.

CME has been the topic of a number of other reports. Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft upped their price target on CME Group from $300.00 to $310.00 and gave the stock a “buy” rating in a research note on Friday. Oppenheimer boosted their price objective on CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a report on Thursday, July 24th. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research report on Tuesday, October 14th. Finally, Raymond James Financial lowered their price objective on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a report on Monday, October 13th. Eight research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $287.65.

CME Group Trading Down 0.1%

NASDAQ CME traded down $0.39 during mid-day trading on Friday, reaching $283.16. 514,186 shares of the stock were exchanged, compared to its average volume of 2,194,437. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market cap of $102.11 billion, a P/E ratio of 27.43, a P/E/G ratio of 4.41 and a beta of 0.38. The stock has a 50 day simple moving average of $266.87 and a 200-day simple moving average of $272.73. CME Group has a one year low of $222.56 and a one year high of $290.79.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. The business had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The business’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.68 EPS.

Institutional Investors Weigh In On CME Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in CME Group by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 35,307,074 shares of the financial services provider’s stock worth $9,539,618,000 after purchasing an additional 130,698 shares during the period. Geode Capital Management LLC boosted its holdings in CME Group by 3.6% in the 2nd quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock valued at $2,524,271,000 after purchasing an additional 319,899 shares during the period. Norges Bank bought a new position in CME Group in the 2nd quarter valued at $1,571,447,000. Ameriprise Financial Inc. increased its holdings in shares of CME Group by 2.0% in the second quarter. Ameriprise Financial Inc. now owns 4,682,066 shares of the financial services provider’s stock worth $1,289,910,000 after purchasing an additional 92,925 shares during the period. Finally, Raymond James Financial Inc. raised its position in shares of CME Group by 9.7% in the first quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider’s stock worth $1,091,401,000 after buying an additional 363,130 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Activity

In other news, insider Timothy Francis Mccourt sold 379 shares of the company’s stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This represents a 3.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the sale, the director owned 1,091 shares in the company, valued at $287,511.23. This represents a 47.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 14,043 shares of company stock worth $3,791,486. 0.30% of the stock is owned by insiders.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Friday, December 12th. CME Group’s dividend payout ratio is 48.45%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.